Ivy Sports Medicine was formed in February of 2011. In June 2011, Ivy Sports Medicine aquired assets from ReGen Biologics out of Chapter 11. The production facility for the Collagen Meniscus Implant (CMI®) was maintained, including the employees. Thus the young company Ivy Sports Medicine has extensive experience in manufacturing and use of the CMI. Ivy Sports Medicine is working on developing simple, comprehensive and data-driven therapies, which enable sports medicine surgeons to restore patient mobility.